University of Texas MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(3) is a clinical research site located in Houston, Texas, United States 77030.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
University of Texas MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(3) has participated in 1 clinical trials.
Therapeutic areas: Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Texas MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(3) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Texas MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(3) has 1 clinical trials on record. Their work covers Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma.
University of Texas MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(3) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.